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Advanced glycation end products (AGEs) that arise from the reaction of sugars with protein side chains and the terminal amino group are
supposed to be involved in the pathogenesis of several diseases and therefore the effects of AGEs on cells are the objective of numerous
investigations. The effects of AGEs on cells are commonly assumed to be transduced via the receptor for AGEs (RAGE) but there are also other
receptors known to interact with AGEs and they are likely to be involved in signal transduction. The primary cellular effect of AGEs on cultured
cells was found to be the formation of reactive oxygen species (ROS). For the present study one murine and three human cell lines were used. The
effects of a set of different highly modified AGEs and AGE-like compounds derived from the incubation of different modifiers with BSA were
tested for their effects on these cells. Almost all AGEs tested induced the production of reactive oxygen species (ROS) in the different cell lines
although the intensity of the detected signals varied considerably between the cell lines and are strongly dependent on the AGE used for cell
activation. The most highly modified BSA-species were shown to inhibit cell growth in all cell lines, whereas a moderately modified glucose
derived BSA-AGE and BSA-GAred did not show any inhibitory effect on cell growth even when a high ROS formation was detected.
© 2006 Elsevier B.V. All rights reserved.Keywords: Advanced glycation end product; AGEs; Reactive oxygen species; ROS; Growth inhibition1. Introduction
Advanced glycation end products (AGEs) arise from a complex
nonenzymatic multi-step reaction of reducing sugars with proteins,
namely their amino acid side chains and the terminal amino group.
In vivo, numerous proteins, particularly long-lived proteins, are
found to be AGE-modified, although only to a minimal degree. In
cell culture studies in vitro prepared AGEs were found to induce
cellular activation associated with chemotaxis, oxidative stress and
cell proliferation or programmed cell death [1], and in vivo AGEsAbbreviations: AGEs, advanced glycation end products; BSA, bovine serum
albumin; CTB, CellTiter Blue; FCS, fetal calf serum; GA, glyoxylic acid; Glc,
glucose; HBSS, Hank's balanced salt solution; H2DCF-DA, dichlorodihydrofluor-
escein diacetate; MALDI-TOFMS, matrix-assisted laser desorption ionization time-
of-flight mass spectrometry; MG, methyl glyoxal; PBS, phosphate buffered saline;
RAGE, receptor for AGESs; ROS, reactive oxygen species
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doi:10.1016/j.bbamcr.2006.07.006are suspected to be involved in the pathogenesis of several diseases
such as chronic clinical complications of diabetes [2], renal failure
[2], and Alzheimer's disease [3]. Although other receptors or
proteins are known to interact with AGEsmany effects of AGEs on
cells are commonly attributed to the interaction of the modified
protein with the receptor for AGEs (RAGE). RAGE is a
transmembrane protein of the immunoglobulin superfamily with
a molecular mass of 45 kDa that was demonstrated to be present in
several cell types such as endothelial cells, monocytes, microglia,
and neurons [4]. The AGE binding to RAGE leads primarily to the
formation of reactive oxygen species (ROS) and hence induces
processes related to cellular activation and inflammation [5] such as
an activation of p21ras, MAP kinases and NF-κB [4]. However,
other receptors interacting with AGEs were previously described
[4,6] and there is also evidence for the existence of other, currently
unidentified proteins interactingwith AGEs [7] and at least some of
these proteins are likely to contribute to the generation of AGE-
induced cellular effects. The induction of ROS as the primary
cellular response toAGE-exposurewas demonstrated in several cell
lines such as rat white adipocytes [8], rat mesangial cells [9],
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ROS formation is awell suited indicator for assaying the occurrence
of AGE-induced effects on cultured cells. The effects of AGEs on
cell proliferation was also previously described, but with very
different results. Glyceraldehyde modified BSA and casein are
found to inhibit cell growth of human promyelocytic leukaemia
cells [12]. Contrarily, a growth stimulation was found in several
studies after treatment with AGEs. Glucose derived BSA-AGEs
were found to stimulate the proliferation of bovine retinal
endothelial cells [13] and glyceraldehyde and glycolaldehyde
AGEs enhanced the proliferation of human melanoma cells while
no or only minor effects were found with glucose and methyl
glyoxal derivedAGEs [14]. However, AGE-derived cellular effects
are strongly dependent not only on the kind of modifier used for
AGE-formation but also on the conditions of incubation and finally
on the resulting degree of modification and the presence of special
structures within the modified protein.
For the present study BSA was modified using different
concentrations of glucose (Glc) and methyl glyoxal (MG) as
well as one concentration of glyoxylic acid (GA) under reducing
conditions. The resulting AGEs were moderately to highly
modified. Although by the definition given above only Glc-
modified proteins are real AGEs, all modified proteins are
referred to as AGEs throughout the text.
The AGEs used in the study were characterized and tested for
their effects in cell culture concerning the formation of ROS and
the cell growth in the presence of AGEs. Four different cell lines
were used for the study. It was found that highly modified AGEs
derived from the incubation of BSAwith Glc or MG inhibit cell
growth and induce the formation of ROS in all cell lines. GA-
modified BSA did cause a significant formation of ROS,
especially in brain cell lines, but did not inhibit cell growth.2. Material and methods
2.1. Materials
Chemicals were purchased from the following suppliers: Sigma-Aldrich
(Germany): BSA, EDTA, glyoxal, methyl glyoxal, and dichlorodihydrofluor-
escein diacetate (H2DCF-DA); Roth (Germany): Roti-Block, and components
for PBS; Pierce, (Germany): ECL-kit and BCA reagent 1 and 2; DAKO
(Denmark): anti-mouse antibody-horseradish peroxidase conjugate; Fluka
(Germany): 2,4-dinitrophenyl hydrazine (2,4-DNPH), 9,10-phenanthrenequi-
none, and NaCNBH3; Amersham Biosciences (Germany): Rainbow marker
756; Merck (Germany): glucose monohydrate, and glyoxylic acid monohydrate;
Promega (Germany): CellTiter Blue reagent; GibcoBRL (Germany) Dulbecco's
modified Eagle's medium (DMEM), Hank's balanced salt solution (HBSS), and
all other components for the cell culture.
2.2. Preparations and characterization of the modified proteins
AGE modified BSA was prepared by incubating 4 mg/ml BSA in 0.5 M
phosphate buffer, pH 8.0 containing 1 mM NaN3 and 1 mM EDTA with:
500 mM glucose, 6 weeks, 37 °C (BSA-Glc 500)
100, 200, and 500 mM glucose, 4 weeks, 50 °C (BSA-Glc 100, 50 °C; 200,
50 °C or 500, 50 °C)
10, 20, 50 mM methyl glyoxal, 4 weeks, 37 °C (BSA-MG 10, 20, or 50)
under sterile conditions. All glassware and the buffer were autoclaved prior to use
to inactivate proteases. BSA incubated under the same conditions but withoutadded modifier was used as control. BSA-GAred was prepared as described
previously [15] by incubating 4 mg/ml BSA with 3 mM glyoxylic acid in the
presence of 0.9 mMNaCNBH3 in 0.5M phosphate buffer for 24 h at 37 °C. BSA
incubated in the presence of NaCNBH3 but without glyoxylic acid was used as
control. After the incubation, protein solutions were extensively dialysed against
10 mM phosphate buffer, pH 7.4 and stored at −20 °C. Protein concentrations
were determined using the BCA assay according to the supplier's protocol.
Characterization procedures were performed as previously described in detail
[16]. Briefly, the number of reacted lysine residues was determined using
fluorescamine. Reacted arginine was assayed using 9,10-phenanthrenequinone as
described previously [16,17]. The CML content was determined by CML-ELISA
kit (kindly provided by Roche Diagnostics, Penzberg, Germany) according to the
supplier's protocol and the carbonyl content was assayed using 2,4-DNPH as
previously described [16,18]. AGE-absorbance was read at 360 nm and AGE-
specific fluorescence was detected at excitation/emission wavelength of 330/
395 nm, 365/440 nm, and 485/530 nm at a protein concentration of 1 mg/ml [16].
Additionally, changes in intrinsic protein fluorescence were detected at excitation/
emission wavelength of 280/350 nm [16]. All data are given normalized to the
corresponding control. Freshly prepared BSA solution was used as an additional
control in all cases.
The masses of the non-modified and modified proteins were detected by
MALDI-TOF MS as described previously [19].
2.3. Cell lines and cell culture
The following cell lines were used for the study: CaCo-2, a human colonic
adenocarcinoma cell line (obtained from DSMZ, Germany); N11 an immorta-
lized murine microglial cell line (kindly provided by Dr. Paola Ricciardi-
Castagnoli, Centre of Cytopharmacology, Milan, Italy); U373 MG, a human
astrocytoma cell line (kindly provided by Dr. Michael Hüll, University of
Freiburg, Germany); and CHME-5, a human embryonic microglial cell line
(kindly provided by Prof. Pierre Talbot, University of Quebec, Canada). Cells
were grown in cell culture flasks (25 cm2, Greiner) in DMEM supplemented with
FCS (10% for N11, U373 MG and CHME-5, 20% for CaCo-2), glutamine, non-
essential amino acids (for CaCo-2) and penicillin/streptomycin at 37 °C, 5%CO2
and 95% humidity and harvested with Trypsin (2 min for N11, U373 MG and
CHME-5, 10 min for CaCo-2). Suspended cells were counted in a CASY 1 cell
counter (Schärfe, Germany) for experiments.
2.4. Detection of RAGE using Western blot analysis
Samples were obtained from cells that were washed twice with PBS before
lysed in Laemmli sample buffer [20] without added bromphenol blue. The
protein concentrations were adjusted by measuring the absorbance of the cell
lysate at 280 nm. SDS-PAGE was performed with equal amounts of protein for
each cell line, according to the procedure of Laemmli [20] using 12% acrylamide
gels in a Mini-PROTEAN 3 chamber (BIO-RAD). Rainbow marker 756 was
used as molecular weight marker. Proteins from unstained SDS-PAGE gels were
blotted onto a nitrocellulosemembrane for 90min at 150A in a Semi-dry blotting
system (C.B.S. Scientific. Co, USA) using a buffer containing 25 mM Tris and
190 mM glycine, pH 8.3 as transfer buffer. Following an 1 h blocking with 10%
Roti-Block the membrane was incubated for 1 h with a monoclonal mouse-anti-
RAGE antibody (kindly provided by Dr. Th. Henle and Dr. Bernd Weigele, TU
Dresden, Germany) in Tris buffered saline (TBS) containing 10% Roti-Block.
The primary antibody was removed by washing the membrane four times with
TBS. Afterwards the blot was incubated for 1 h with a monoclonal anti-mouse
IgG conjugated with horseradish peroxidase in TBS containing 10%Roti-Block.
Unbound antibodywas removed bywashing themembranes four timeswith TBS
containing 0.05% Tween 20. Bound antibody was detected using the ECL-assay
according to the supplier's protocol.
2.5. CellTiter Blue cell survival assay
Cell growth in the presence of AGEs was assayed using the CellTiter Blue cell
viability assay. 10000 cells in case of CaCo-2 and 5000 cells for the brain cell lines
were seeded into 96-well cell culture plates (TPP, Switzerland) in 100μlmediumand
50 μl of the protein sample (final concentration of protein sample 15 μM). The cells
Fig. 1. Western blot image of the detection of RAGE in the lysates of CaCo-2
(lane 1), CHME-5 (lane 2), N11 (lane 3), and U373 MG (lane 4). Cells were
lysed in Laemmli buffer (without bromphenol blue) and the protein
concentrations in the cell lysates were adjusted by measuring the absorbance
at 280 nm.
Table 1
Data for AGA-characterization for the AGEs used in the study
MW
[Da]
Lysine
%mod.
Arginine
% mod.
mol CML/
mol BSA
mol carbonyl/
mol BSA
BSA 66553 0 0
BSA-Glc 500 71582 69 30 1.14 3.3
control BSA-Glc 500 66475 0 0 0 0
BSA-MG 10 71808 59 67 0.09 4.4
BSA-MG 20 72177 82 78 0.41 7.1
BSA-MG 50 76484 96 88 0.95 12.0
control BSA-MG
10–50
66562 0 0 0 0
BSA-Glc 100, 50 °C 70673 67 53 4.90 3.8
BSA-Glc 200, 50 °C 72896 86 62 5.13 5.0
BSA-Glc 500, 50 °C 75774 95 73 5.34 7.2
control BSA-Glc
100–500, 50 °C
66478 0 0 0 0
BSA-GAred 67291 35 8 0.80 0
control BSA-GAred 66506 0 0 0 0
The data are given either in % modified compared to the corresponding control
(degree of reacted arginine and lysine side chains) or in mol modifications per
mol BSA (CML and carbonyl groups).
Table 2
Spectrospic data for the AGEs used in the study
A [360]
AU
Fluo
[280/350]
% of
control
Fluo
[330/395]
norm.
control
Fluo
[365/440]
norm.
control
Fluo
[785/530]
norm.
control
BSA-Glc 500 0.36 10 32 32 34
control BSA-
Glc 500
0 100 1 1 1
BSA-MG 10 1.10 1.7 47 40 95
BSA-MG 20 2.10 0.5 24 39 122
BSA-MG 50 3.61 0.0 11 15 123
control BSA-MG
10–50
0 100 1 1 1
BSA-Glc 100, 50 °C 0.91 4.0 19 12 65
BSA-Glc 200, 50 °C 1.50 1.5 18 11 85
BSA-Glc 500, 50 °C 1.55 0.7 14 8 79
control BSA-Glc
100–500, 50 °C
0 100 1 1 1
BSA-GAred 0 94 1 1 1
control BSA-GAred 0 100 1 1 1
The data are given normalized to the corresponding control. For the AGE
specific absorbance at 360 nm the absorbance of BSA control at 280 nm was
used to normalize the data.
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Blue reagent were mixed with 8.5 ml fresh medium and 100 μl of the solution were
added to the cells. The brain cell lines were incubated for 1.5 h and CaCo-2 for 3 h
before fluorescence was detected at excitation/emission wavelengths of 540/590 nm
in a FLUO-STAR plate reader (BMG, Germany).
2.6. Reactive oxygen species assay
The AGE-induced formation of reactive oxygen species was measured using
dichlorodihydrofluorescein diacetate (H2DCFDA) as described previously [11] with
some modifications. 10000 cells per well were seeded in a total volume of 100 μl
medium (as described in the cell culture paragraph) in 96-well cell culture plates
(TPP, Switzerland) and grown for 48 h (CaCo-2) or 24 h (brain cell lines). The
medium was removed and each well was washed with 150 μl HBSS before loading
the cells with H2DCF-DA (100 μl, 0.1 mM in HBSS) for 1 h. The dye reagent was
removed and the wells were washed with 150 μl HBSS. Samples were added in a
total volume of 100 μl with a protein concentration of 10 μM in HBSS. Freshly
preparedBSA-solutionwas used as control. After a 20 h incubation fluorescencewas
read at excitation/emission wavelengths of 485/520 nm in a FLUO-Star reader
(BMG,Germany).Wells containing cells and protein but no dyewere used to correct
the detected signals for the AGE fluorescence.
2.7. Statistics
All data given in the text represent the averages of three independent
experiments with at least 3 data-points. All values are given normalized to the
value obtained with non-incubated BSA-solution.
The data were compared to the data obtained with non-incubated BSA-
solution by Student's t test. Significances are given as * (P=0.01–0.05),
** (P=0.001–0.01), and *** (P<0.001).
3. Results
3.1. Presence of RAGE in the cell lines
The presence of RAGE in the cell lines used in the study was
probed by Western blot using a monoclonal antiRAGE antibody.
As shown in Fig. 1 RAGE was found to be present in all cell lines
used in the study. The results for N11 and CaCo-2 cells are
consistent with previous studies, where RAGE was demonstrated
in CaCo-2 by RT-PCR and Western blot [21] and in N11 by
Western blot [22]. According to the literature CHME-5 and U373
MG cells were not previously tested for the receptor for AGEs. The
presence of RAGE in the cell lines used is assumed to prove the
general ability of the cells to interact with AGEs and should not
imply that all effects described in the present study are necessarily
mediated by RAGE.
3.2. Characterization of the AGEs used in the study
The characterization data of all modified proteins used in the
study are given in Table 1 (molecular masses and side chainmodifications) and Table 2 (spectroscopic data). The AGEs
were prepared at 37 °C unless otherwise stated. The BSA-AGEs
derived from the incubation with Glc at 50 °C and with MG
show the highest degrees of modification although the degree of
arginine modification is higher for MG than for Glc derived
modified BSA. Accessible CML groups are found in all
modified proteins. The highest numbers of CML-modifications
were detected in the BSA-AGEs produced at 50 °C, while the
CML-content of the proteins modified with MG is relatively
low. However, even BSA-GAred, that was prepared in accor-
dance to a protocol that is assumed to result mainly in the
formation of CML-modifications [15], contains only 0.8 mol
accessible CML per mol BSA. The carbonyl content, which is a
Fig. 2. Cell growth of CaCo-2 cells in the presence of differently modified BSA. Cells were seeded and grown for 48 h in the presence of 15 μM protein sample in
standard medium. The cell growth was determined using the CellTiter Blue assay in fresh medium.
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is highest in 50 mM MG derived BSA-AGE followed by the
AGE from in the incubation with 500 mM Glc at 50 °C. No
carbonyl groups could be detected in BSA-GAred.
AGE specific absorbance was detected at 360 nm. The given
data are normalized to the absorbance at 280 nm of the
corresponding control, since non-modified BSA shows no
absorbance at 360 nm [16]. Changes in the protein structure were
detected using the intrinsic protein fluorescence of tryptophan.
The native structure was found to be significantly affected in all
modified proteins except BSA-GAred, which shows only aminor
decrease in the intrinsic protein fluorescence. AGE specific
fluorescence was detected at the wavelengths indicated and wasFig. 3. Cell growth of N11 cells in the presence of differently modified BSA. Cells we
medium. The cell growth was determined using the CellTiter Blue assay in fresh mfound to be high for all modified proteins except BSA-GAred,
which is virtually non-fluorescent. However, compared to fresh
BSA even the BSA control incubated at 50 °C without modifier
shows significantly affected spectroscopic data (data not shown
in Table 2). The intrinsic protein fluorescence was found to be
reduced to 70% of the value obtained with fresh BSA and the
AGE-specific fluorescences were enhanced by a factor of 6, 12,
and 4 at excitation/emission wavelength of 330/395 nm, 365/
440 nm, and 485/530 nm when compared to fresh BSA. This is
probably a result of the relatively drastic incubation conditions,
that are likely to affect the native protein structure and from
ongoing AGE-formation processes of already existing glyca-
tion-structures within the virtually non-modified protein. There seeded and grown for 48 h in the presence of 15 μM protein sample in standard
edium.
Fig. 4. Cell growth of U373 MG cells in the presence of differently modified BSA. Cells were seeded and grown for 48 h in the presence of 15 μM protein sample in
standard medium. The cell growth was determined using the CellTiter Blue assay in fresh medium.
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cences when compared to fresh BSA.
3.3. Cell growth in the presence of AGEs
The results from the cell growth experiments for all cell lines
are shown in Figs. 2–5. The data represent the averages of three
individual experiments with at least 3 data-points. All data are
given normalized to the signal obtained when using freshly
prepared BSA-solution. As obvious from the figures, only the
very highly modified BSA-species, especially the MG-derived
AGEs, were able to inhibit cell growth at the applied conditions.
Neither BSA-AGE derived from the incubation with 500 mM
Glc at 37 °C nor the BSA-GAred had any effect on the cellFig. 5. Cell growth of CHME-5 cells in the presence of differently modified BSA. C
standard medium. The cell growth was determined using the CellTiter Blue assay ingrowth of all cell lines used in the study. N11 and U373 MG
cells are only slightly growth-inhibited in the presence of BSA-
AGEs derived from the incubation with glucose at 50 °C,
whereas the cell number of CaCo-2 and CHME-5 is sig-
nificantly reduced compared to the control when grown in the
presence of these AGEs. Interestingly, CHME-5 did even show
a relatively strong response on the different degrees of modi-
fication with these Glc-modified proteins, which was not found
for the other cell lines.
The concentration dependence of the growth inhibiting effect
of BSA-MG 50 on CHME-5 is shown in Fig. 6. The growth
inhibition was found to be concentration dependent although
only slight differences were found in the effects caused by the
different AGE-concentrations used.ells were seeded and grown for 48 h in the presence of 15 μM protein sample in
fresh medium.
Fig. 6. Cell growth of CHME-5 in the presence of increasing concentrations of BSA-MG 50. Cells were seeded and grown for 48 h in the presence of the indicated
sample concentrations in standard medium. The cell growth was determined using the CellTiter Blue assay in fresh medium.
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response to AGEs
The results from the ROS-assays for all cell lines are shown
in Figs. 7–10. The data represent the averages of three
individual experiments with at least 3 data-points. The data
were corrected for the intrinsic AGE-fluorescence before
evaluation. All data are given normalized to the signal obtained
when using freshly prepared BSA-solution. As shown in Figs.
7–10 all cell lines produced ROS in the presence of AGEs, but
the efficiency of the different AGE-proteins varied consider-
ably between the cell lines. Remarkable differences are found
for GA-modified BSA, which caused a high ROS formation in
all brain cell lines, whereas CaCo-2 cells were only slightly
stimulated. In U373 MG and CHME-5 cells BSA-GAred caused
the highest ROS-signals among all AGEs tested. The control
for BSA-GAred did also cause a moderately enhanced ROS-Fig. 7. Data obtained for the stimulation of CaCo-2 cells with differently modified BS
in HBSS. The data are given normalized to the signal obtained with fresh BSA.production in the brain cell lines as compared to fresh BSA.
This might be an effect caused by the incubation of the protein
in the presence of NaCNBH3. The second protein with
significantly different cell responses is the BSA-AGE derived
from the incubation with 500 mM Glc at 37 °C. While CaCo-2
cells were considerably stimulated by this protein, no or only
minor stimulation was detected in all brain cell lines. This is an
unexpected finding because the BSA-Glc 500, 37 °C was
found to contain 1.14 mol/mol accessible CML groups, which
was previously reported to be an important cell affecting
modification [24] and should therefore cause at least some
stimulation. Thus, other modifications than CML seem to be
responsible for the formation of ROS in the brain cell lines. The
other AGEs tested induced a high ROS-formation in all cell
lines, although CaCo-2 and N11 were more stimulated by these
highly modified AGEs than U373 MG and CHME-5 cells. In
CaCo-2 and N11 cells a slightly enhanced ROS-formation canA. The stimulation was performed for 20 h with a sample concentration of 10 μM
Fig. 8. Data obtained for the stimulation of N11 cells with differently modified BSA. The stimulation was performed for 20 h with a sample concentration of 10 μM in
HBSS. The data are given normalized to the signal obtained with fresh BSA.
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50 °C.
4. Discussion
As shown above the presence of AGEs derived from
incubation of BSA with glucose, methyl glyoxal, or glyoxylic
acid (under reducing conditions) under different conditions
caused the formation of ROS and inhibited cell growth in the
cell lines studied. The proteins used in the present study are
highly modified with a degree of modification with at least
35% of lysine and 8% of arginine residues modified. Although
the degrees of modification of the AGEs used are non-
physiologic it should be mentioned that the complicationsFig. 9. Data obtained for the stimulation of U373 MG cells with differently modifie
10 μM in HBSS. The data are given normalized to the signal obtained with fresh Bcaused by AGEs in vivo are usually a result of long-term
exposure of cells to minimally modified AGE-proteins, which
might in vivo be modified from different sugars or dicarbonyl
compounds in a long term process. As cell culture incubation
is usually done using very short incubation times and low
protein concentrations (when compared to physiological
conditions), the use of highly modified AGEs, although they
are non-physiologically modified, is assumed to be a valuable
model to study the general effectiveness of AGEs in cell
damaging processes. In the present study cell growth was most
effectively inhibited by MG derived AGEs, whereas a strong
ROS formation was observed not only with MG derived
AGEs but also with Glc-AGEs prepared at 50 °C, and in the
brain cell lines with BSA-GAred.d BSA. The stimulation was performed for 20 h with a sample concentration of
SA.
Fig. 10. Data obtained for the stimulation of CHME-5 cells with differently modified BSA. The stimulation was performed for 20 h with a sample concentration of
10 μM in HBSS. The data are given normalized to the signal obtained with fresh BSA.
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found to be growth inhibited by the Glc-AGEs produced at 50 °C
and by MG-AGEs. The BSA-Glc 500 produced at 37 °C and
BSA-GAred did not show a significant effect on cell growth.
Therefore, our results are in contrast to previous findings, where
a stimulation of cell proliferation was found after AGE-treatmentFig. 11. Correlation of the CTB fluorescence versus the AGE-absorbance a[13,14] and in agreement with results published by Usui et al.,
who found a growth inhibiting effect of AGEs [12]. However,
the effects of AGEs are strongly dependent not only on the cell
lines and the conditions used for the tests, but also on the kind of
AGE (modifier, conditions for incubation, resulting degree and
kind of modification) and hence, a comparison of data fromt 360 nm for CaCo-2 (A), CHME-5 (B), N11 (C), and U373 MG (D).
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the test is almost impossible. But when using identical
conditions for different cell lines as done in the present study,
comparable results were obtained, although the extend of growth
inhibition varied from cell line to cell line. However, when
searching for the AGE-characteristics, that are correlated to the
growth inhibiting effects of the AGEs used in the study, it was
found that the decrease in the CTB-fluorescence in AGE-treated
cells is linearly correlated to the increase in AGE-absorbance at
360 nm (Fig. 11). This parameter was previously found to be a
useful tool for the biochemical characterization of AGEs [16,19]
and could now be shown to also correlate with the growth
inhibiting effect of AGEs. A similar correlation was found with
the molecular mass of the AGEs and the degree of modification,
although they were not that exact as the correlation with the A
[360] (data not shown). The AGE specific fluorescence or the
number of CML or carbonyl groups did not correlate with the
growth inhibiting effects of the AGEs.
For the AGE-induced intracellular ROS formation no
correlation with AGE-parameters could be found that was
valid for all cell lines. For CaCo-2 the formation of ROS was
linearly correlated with the degree of arginine modifications
(data not shown) but this correlation was not applicable for any
of the other cell lines, where BSA-Glc 500 (37 °C) did not cause
any ROS formation, while having 30% of arginine groups
modified. Contrarily, BSA-GAred had only 8% of arginine
groups modified and caused a very high ROS formation in the
brain cell lines. However, all AGEs used in the study induced
the formation of significant amounts of ROS, except for BSA-
Glc 500 (37 °C) in the brain cell lines. This is somewhat
unexpected, because this AGE was produced according to a
more or less often used standard protocol and similar AGEs
were found to induce cellular effects in different studies (e.g.
[8,13]). Contrarily, although different cells and different cellular
parameters were studied, Valencia et al. found a lack of VCAM1
and TNF-α activating activity for similar AGEs [25], what is in
agreement with the lack of growth inhibiting and ROS-
formation activity of BSA-Glc 500 (37 °C) observed in the
present study.
Interestingly, the formation of ROS seems to be not
necessarily correlated to the cytotoxic effects of AGEs. While
a high ROS production and growth inhibition was observed
with Glc-AGEs (50 °C) and MG-AGEs, BSA-GAred did cause a
high formation of ROS, especially in the brain cell lines,
without any effect on cell growth. This suggests, that the ROS-
formation caused by BSA-GAred might induce a different
intracellular signalling pathway than the other AGEs in the
study, or that the growth inhibiting effect is ROS-independent
cell response caused by modifications, that are not found in
BSA-GAred but in the other AGEs.
Most controversial are the data obtained with BSA-GAred,
which was prepared in accordance to a protocol that is assumed
to result in a more or less specifically CML-modified protein
[15,24]. But it was shown in the characterization, that the BSA
modified with GA under reducing conditions, which should be
CML-modified, most likely contains a high number of
modifications other than CML (mass increase of 765 Dacompared to the corresponding control, 27% of reactive side
chains modified). BSA-GAred did cause a high production of
ROS in the brain cell lines and also a moderately increased
signal in CaCo-2, whereas there was no growth inhibiting effect
detectable in the CTB assay. However, as shown in Table 1, the
accessible CML content was found to be much higher in the
glucose derived BSA-AGEs than in BSA-GAred. Anyhow, the
BSA-Glc 500 (37 °C) did not cause any ROS-formation in the
brain cell lines and the ROS-formation in CHME-5 and U373
MG cells caused by the 50 °C Glc-AGEs (accessible CML 4.9–
5.3 mol per mol BSA) was significantly lower than the signal
with BSA-GAred. Therefore, it can be concluded that either
CML is not the modification that is responsible for the high
production of ROS, or that the presence of CML alone is not
sufficient for the signal transduction pathway leading to growth
inhibition. It is also possible, that a combination of CML with
another modification serves as the binding motif within the
modified protein.
5. Conclusion
In the present study it was shown that exposure of cultured
cells to differently prepared AGEs resulted in reduced cell
growth and intracellular ROS formation. Different AGEs were
shown to cause different intensities in cellular response and
the results did also vary from cell line to cell line. Growth
inhibition was strongest with MG derived AGEs and could
also clearly be demonstrated with Glc-AGEs from incubation
at 50 °C. The growth inhibiting effect was found to be in good
correlation with the absorbance at 360 nm of the AGE samples
used.
Additionally, almost all AGEs in the study did provoke the
formation of intracellular ROS, but this effect could not be
correlated to any of the parameters from the AGE-character-
ization. Furthermore, a high ROS-formation is not necessarily
related to a strong growth inhibiting effect. This could clearly
be shown for BSA-GAred, that did induce a high ROS
production in brain cell lines but had no growth inhibiting
effect. Therefore, ROS formation and growth inhibition in
response to AGE exposure might be transduced by indepen-
dent or partially independent signalling pathways that might
be caused by different modifications or even by different
AGE-receptors.
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